EUVIMEDEUVIMED entdecken
Crossref

An NIR/GSH-responsive nanoplatform based on tetrasulfide bridging for targeted synergistic tumor therapy

Lincui Da, Yingchao Li, Ziyan Zheng, Yanying Lin, Lili Chen, Baoming Li, Haixia Lyu, Beihong Zheng, Yan Sun

Colloids and Surfaces B: Biointerfaces · 2026

DOI: 10.1016/j.colsurfb.2026.115656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Lincui Da und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetric & Gynecology and Pediatrics, C…. Hauptthemen laut MEDLINE: Glutathione, Nanoparticles, Sulfides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficient treatment of malignant tumors remains a major challenge in the biomedical field. To address the high toxicity and side effects of traditional chemotherapy, poor tumor targeting, and the limited effectiveness of single therapy, this study developed an intelligent nanoplatform (USMFC) that responds to both near-infrared (NIR) light and the tumor microenvironment by integrating upconversion nanoparticles (UCNPs), a tetrasulfide-bridged mesoporous silica (mSiO₂) shell, and folic acid (FA) for active tumor targeting, with polyethylene glycol (PEG) electrostatically adsorbed as the outermost layer. Under 980 nm excitation, the red emission from the UCNPs activated the photosensitizer methylene blue, enabling deep-tissue photodynamic therapy (PDT). The tetrasulfide bridges are cleaved in the high-glutathione (GSH) tumor microenvironment, triggering the controlled release of doxorubicin (DOX) (up to 82.3%), while simultaneous GSH depletion results in a 2.6-fold increase in effective ROS production and enhanced PDT efficacy. Additionally, Cu₂S nanoparticles confer excellent photothermal performance (36.2% conversion efficiency), enabling photothermal therapy (PTT) and photothermally enhanced release of the drug DOX. The modification of the outermost PEG layer further endows the nanoplatform with improved colloidal stability and biosafety. In vitro cell experiments confirmed that the nanoplatform has good biocompatibility and efficient cell uptake ability and effectively kills tumor cells through the triple synergistic effect of PDT/PTT/chemotherapy, reducing the survival rate of 4T1 cells to 18.3% at a concentration of 150 μg/mL. This study provides a new strategy for efficient and low-toxicity synergistic tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutathioneNanoparticlesSulfidesDoxorubicinAnimalsInfrared RaysPhotochemotherapyPolyethylene GlycolsHumansMicePhotosensitizing AgentsCell Line, TumorSilicon DioxideFolic AcidCell SurvivalReactive Oxygen SpeciesTumor MicroenvironmentMethylene Blue

Stichwörter der Autor:innen

ChemotherapyPhotodynamic therapyPhotothermal therapySynergistic tumor therapyUpconversion nanoparticles

Substanzen

GlutathioneDoxorubicinPolyethylene GlycolsSulfidesPhotosensitizing AgentsSilicon DioxideFolic AcidReactive Oxygen SpeciesMethylene Blue

Autor:innen und Institutionen

  • Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetric & Gynecology and Pediatrics, China. Electronic address: dalincui@163.com.
  • College of Materials Science and Engineering, Fuzhou University, China. Electronic address: 811282681@qq.com.
  • College of Materials Science and Engineering, Fuzhou University, China. Electronic address: 599318429@qq.com.
  • Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetric & Gynecology and Pediatrics, China. Electronic address: linyanying21@163.com.
  • Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetric & Gynecology and Pediatrics, China. Electronic address: chenlili@fjsfy.com.
  • College of Materials Science and Engineering, Fuzhou University, China. Electronic address: libaoming@fzu.edu.cn.

Förderung

  • Natural Science Foundation of Fujian Province

Zitieren

APA

Da, L., Li, Y., Zheng, Z., Lin, Y., Chen, L., Li, B., Lyu, H., Zheng, B., & Sun, Y. (2026). An NIR/GSH-responsive nanoplatform based on tetrasulfide bridging for targeted synergistic tumor therapy. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2026.115656

Vancouver

Da L, Li Y, Zheng Z, Lin Y, Chen L, Li B, et al. An NIR/GSH-responsive nanoplatform based on tetrasulfide bridging for targeted synergistic tumor therapy. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2026.115656

BibTeX
@article{Da2026,
  author = {Da, Lincui and Li, Yingchao and Zheng, Ziyan and Lin, Yanying and Chen, Lili and Li, Baoming and Lyu, Haixia and Zheng, Beihong and Sun, Yan},
  title = {An NIR/GSH-responsive nanoplatform based on tetrasulfide bridging for targeted synergistic tumor therapy},
  journal = {Colloids and Surfaces B: Biointerfaces},
  year = {2026},
  doi = {10.1016/j.colsurfb.2026.115656}
}
Kostenlos starten →